Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 25 (2) , 160-170
- https://doi.org/10.1016/0090-8258(86)90097-1
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomasGynecologic Oncology, 1985
- Clinical pharmacokinetics of high-dose mitomycin CCancer Chemotherapy and Pharmacology, 1984
- Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: Preliminary results of a phase I-II studyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancerAmerican Journal of Clinical Oncology, 1983
- Renal disease after mitomycin c therapyCancer, 1981
- High-performance liquid chromatographic determination of the antitumor agent mitomycin c in human blood plasmaAnalytica Chimica Acta, 1981
- Effectiveness of a sequential combination of bleomycin and mitomycin-C on an advanced cervical cancerCancer, 1978
- MITOMYCIN-C, VINCRISTINE, AND BLEOMYCIN THERAPY FOR ADVANCED CERVICAL-CANCER1978
- Mitomycin C: a reviewCancer Treatment Reviews, 1976
- A rapid and simple procedure for chronic cannulation of the rat jugular vein.Journal of Applied Physiology, 1974